What Happened?
Berkeley, CA-based Kyverna-Therapeutics Appointed Dominic Borie as Chief Executive Officer
About the Company
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Our therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of disease. Kyverna is venture-backed and located in the San Francisco East Bay.
About the Person
Dominic Borie is Chief Executive Officer at Kyverna Therapeutics. Previously, Dominic held various senior HR leadership roles in the industry.
Info Source
News
Short Profile